The ROE as of April 2026 (TTM) for Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) is 2.59%

According to Drugs Made In America Acquisition Corp. Ordinary Shares’s latest financial reports and current stock price. The company's current ROE is 2.59%. This represents a change of 298.87% compared to the average of 0.65% of the last 4 quarters.

Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) Historical ROE (quarterly & annually)

How has DMAA ROE performed in the past?

The mean historical ROE of Drugs Made In America Acquisition Corp. Ordinary Shares over the last ten years is 99.43%. The current 2.59% ROE has changed -97.39% with respect to the historical average. Over the past ten years (40 quarters), DMAA's ROE was at its highest in in the June 2024 quarter at 275.61%. The ROE was at its lowest in in the December 2025 quarter at 0.09%.

Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) ROE by Quarter and Year

Discovering the peaks and valleys of Drugs Made In America Acquisition Corp. Ordinary Shares ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) Average ROE

How has DMAA ROE performed in the past?

The current ROE of Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) ROE vs. Peers

How is DMAA’s ROE compared to its peers?

Drugs Made In America Acquisition Corp. Ordinary Shares’s ROE is less than SIM Acquisition Corp. I (3.83%), less than Mountain Lake Acquisition Corp. (3.57%), less than Berto Acquisition Corp. Unit (5.47%), less than Centurion Acquisition Corp. (6.86%), less than Berto Acquisition Corp. (3.57%), greater than Live Oak Acquisition Corp. V Class A Ordinary Shares (-7.51%), less than Titan Acquisition Corp. (3.57%), less than Oyster Enterprises II Acquisition Corp (4.72%), less than Renatus Tactical Acquisition Corp I Class A Ordinary Shares (3.12%),

Build a custom stock screener for Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Drugs Made In America Acquisition Corp. Ordinary Shares using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Drugs Made In America Acquisition Corp. Ordinary Shares or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.